The discussion dives into the alarming rise in Rocky Mountain spotted fever cases, highlighting a dramatic increase from under 500 to over 6000 cases in just 17 years. While the case fatality rate in the U.S. has significantly decreased, concerns arise about the accuracy of diagnoses and reporting. In contrast, Mexico experiences a troubling trend with rising fatality rates, emphasizing the need for better global surveillance and understanding of this disease.
